Cargando…
In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor
Autores principales: | Kurzik-Dumke, Ursula, Hörner, Manuela, Nicotra, Maria R, Koslowski, Michael, Natali, Pier G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909173/ https://www.ncbi.nlm.nih.gov/pubmed/20565727 http://dx.doi.org/10.1186/1479-5876-8-58 |
Ejemplares similares
-
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli, Meysam, et al.
Publicado: (2019) -
The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017) -
A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016) -
FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005) -
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)